These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2588151)

  • 1. [Effect of specific immunotherapy on the structural properties of the lymphocyte membranes in atopic diseases].
    Cherkashin SIu; Nagornaia IN; Tananko EM; Dymshits LB; Nosikova TA
    Ter Arkh; 1989; 61(7):95-7. PubMed ID: 2588151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophobic probe's fluorescence intensity. 3-methoxybenzanthrone (3-MBA) in bronchial asthma and urticaria patients lymphocyte membranes.
    Pytsky VI; Egorova MV; Smirnova SV
    Allergol Immunopathol (Madr); 1988; 16(4):237-42. PubMed ID: 3228044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of specific immunotherapy on peripheral T-lymphocytes in atopic patients].
    Anania A; Marino G; Cascio G
    Minerva Med; 1996 Jun; 87(6):263-7. PubMed ID: 8700354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the surface area and viscosity of membranes in T- and B-lymphocytes by means of fluorescent probes].
    Baglaev TN; Ataullakhanov RI; Dobretsov GE; Kochina IS
    Biofizika; 1983; 28(1):142-4. PubMed ID: 6600940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymphocyte apoptosis--one of mechanisms of specific immunotherapy of atopic diseases].
    Poriadin GV; Salmasi ZhM; Makarkov AI
    Biull Eksp Biol Med; 1998 Apr; 125(4):434-6. PubMed ID: 9631730
    [No Abstract]   [Full Text] [Related]  

  • 6. The early effect of specific immunotherapy on lymphocyte response to PHA and allergens in atopic patients with allergic rhinitis.
    Kinikli G; Tülek N; Sentürk T; Turgay M; Tutkak H; Duman M; Tokgöz G
    Allergol Immunopathol (Madr); 1996; 24(2):65-9. PubMed ID: 8933891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clinical evaluation of different schedules for specific immunotherapy and a comparative analysis of the changes in immunity in pollinosis].
    Petrovskaia IA; Bobkova LP; Evseeva TA; Kostiuk AG; Glinskiĭ VV
    Ter Arkh; 1989; 61(12):56-60. PubMed ID: 2629148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation.
    Malm-Erjefält M; Greiff L; Ankerst J; Andersson M; Wallengren J; Cardell LO; Rak S; Persson CG; Erjefält JS
    Clin Exp Allergy; 2005 Oct; 35(10):1334-40. PubMed ID: 16238793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differences in leukocyte membranes detectable by a fluorescent probe in chronic leukemias].
    Baglaev TN; Kalinin NN; Dobretsov GE; Kosankova ST; Vladimirov IuA
    Biull Eksp Biol Med; 1982 Apr; 93(4):35-7. PubMed ID: 6952943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in functional activity of blood neutrophils in pollenosis patients: effects of specific immunotherapy].
    Ivanova IP; Tananko EM; Shirinskiĭ VS
    Ter Arkh; 1999; 71(4):57-60. PubMed ID: 10358867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An evaluation of the long-term effect of clustered immunotherapy in house-dust-mite-sensitive adult bronchial asthma].
    Nagata M; Tanaka K
    Arerugi; 2001 May; 50(5):435-9. PubMed ID: 11436329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life.
    Zeldin Y; Weiler Z; Magen E; Tiosano L; Kidon MI
    Isr Med Assoc J; 2008 Dec; 10(12):869-72. PubMed ID: 19160945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The extracorporeal immunopharmacotherapy of severe glucocorticoid-dependent atopic diseases].
    Kurbacheva OM; Poroshina IuA; Chitaeva VG; Leskov VP; Prozorovskiĭ NS; Fedenko ES; Gushchin IS
    Ter Arkh; 1992; 64(8):73-6. PubMed ID: 1440403
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cell-mediated immunity in patients with atopic allergic diseases].
    Kosturkov G; Bozhkov B; Savov S; Dimitrov V
    Vutr Boles; 1986; 25(4):60-6. PubMed ID: 3490058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy of allergic diseases: present and future].
    Müller U
    Schweiz Med Wochenschr; 1983 Dec; 113(52):1982-8. PubMed ID: 6229874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grass-pollen allergy.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Vaccine; 2006 Nov; 24(47-48):6990-3. PubMed ID: 17011086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyposensitization treatment of allergic diseases].
    Wüthrich B
    Schweiz Rundsch Med Prax; 1993 May; 82(18):529-33. PubMed ID: 8497762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.